Università Cattolica del Sacro Cuore
Milan, 20123, Italy
Location status: Recruiting
NCT Number: NCT07447089
The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.
Interested in participating?
Request Info18 year–100 year
All sexes
Interventional
Not applicable
Milan, 20123, Italy
Location status: Recruiting
The diagnosis of cancer represents a potentially life-threatening event that can be considered a unique traumatic stressor. A cancer diagnosis can disrupt a person's life, affecting emotions, cognition, and physical pain impacting the individual sense of identity. Findings from the literature suggest that EMDR can be a valid treatment in the processing of cancer-related traumatic events. With this proposal, the investigators aim to evaluate the feasibility and the effects of a combined EMDR Integrative Group Treatment Protocol and an optional EMDR individual protocol for people with cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention follows the EMDR 8-phase protocol as indicated by Jarero et al. (2018). The group sessions use the IGTP-OTS (Integrative Group Treatment Protocol for Ongoing Traumatic Stress) to provide early stabilization.
Other names: EMDR (classic individual setting)
Time frame: Baseline (T1) and Post-intervention (T2, approximately 1 month), Follow-up (T3, approximately 3 month)
Impact of Event Scale-Revised range: The scale is composed by 22 items, each scored 0-4 (Min Score: 0; Max Score: 88).
A higher score indicates a higher intensity of post-traumatic stress symptoms
Contact information is provided by the study sponsor or research team.
Università Cattolica di Milano
Other
Combination of the EMDR Integrative Group Protocol and Individual EMDR Treatment in Patients With Advanced Thyroid Cancer: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06853925
Endocrine Gland Neoplasms, Endocrine System Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05022667
Endocrine Gland Neoplasms, Endocrine System Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT01005654
Adrenal Gland Diseases, Adrenal Gland Neoplasms
Bethesda, Maryland, United States
View Trial DetailsNCT06638931
Adenocarcinoma, Adenoid Cystic Carcinoma
Fortaleza, Ceará, Brazil
View Trial Details